A detailed history of Us Bancorp \De\ transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,782 shares of ALLO stock, worth $3,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,782
Previous 1,570 13.5%
Holding current value
$3,474
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$2.08 - $3.5 $440 - $742
212 Added 13.5%
1,782 $4,000
Q2 2024

Aug 06, 2024

SELL
$2.23 - $4.38 $4,042 - $7,940
-1,813 Reduced 53.59%
1,570 $3,000
Q4 2023

Feb 09, 2024

BUY
$2.28 - $3.5 $1,883 - $2,891
826 Added 32.3%
3,383 $10,000
Q3 2023

Nov 03, 2023

BUY
$3.17 - $5.96 $2,723 - $5,119
859 Added 50.59%
2,557 $8,000
Q2 2023

Aug 09, 2023

BUY
$4.53 - $6.74 $5,481 - $8,155
1,210 Added 247.95%
1,698 $8,000
Q1 2023

May 09, 2023

SELL
$4.92 - $8.21 $13,982 - $23,332
-2,842 Reduced 85.35%
488 $2,000
Q4 2022

Feb 13, 2023

SELL
$5.62 - $11.11 $8,952 - $17,698
-1,593 Reduced 32.36%
3,330 $20,000
Q3 2022

Oct 27, 2022

SELL
$10.32 - $17.28 $5,686 - $9,521
-551 Reduced 10.07%
4,923 $54,000
Q2 2022

Aug 01, 2022

BUY
$6.78 - $12.28 $10,956 - $19,844
1,616 Added 41.89%
5,474 $63,000
Q1 2022

May 11, 2022

BUY
$7.65 - $15.29 $7,726 - $15,442
1,010 Added 35.46%
3,858 $35,000
Q4 2021

Feb 11, 2022

BUY
$13.13 - $24.52 $30,212 - $56,420
2,301 Added 420.66%
2,848 $42,000
Q3 2021

Nov 10, 2021

SELL
$21.01 - $27.64 $207,221 - $272,613
-9,863 Reduced 94.75%
547 $14,000
Q2 2021

Aug 05, 2021

BUY
$23.49 - $35.8 $986 - $1,503
42 Added 0.41%
10,410 $271,000
Q1 2021

Apr 28, 2021

BUY
$25.79 - $39.02 $259,731 - $392,970
10,071 Added 3390.91%
10,368 $366,000
Q4 2020

Feb 04, 2021

BUY
$25.24 - $43.45 $6,234 - $10,732
247 Added 494.0%
297 $7,000
Q3 2020

Nov 10, 2020

SELL
$32.38 - $44.96 $744 - $1,034
-23 Reduced 31.51%
50 $2,000
Q2 2020

Aug 07, 2020

BUY
$18.39 - $54.04 $422 - $1,242
23 Added 46.0%
73 $3,000
Q3 2019

Nov 08, 2019

BUY
$26.11 - $32.99 $1,305 - $1,649
50 New
50 $1,000

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $280M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.